A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
Clinical trial NCT01094496 · TERMINATED
Trial details
- NCT number
- NCT01094496
- Sponsor
- Celldex Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.